Group items tagged

Thinking about Career Planning in Post Graduate Diploma in Healthcare Quality Management? Check out here how to apply and where to apply

Managing Blood Clots during Breast Cancer treatment - Move your legs regularly if you have to stay seated for a long time. Flex and rotate your ankles and lift your knees up and down at least 10 times each hour.

Medical management for Obesity is recommended under supervision of an Endocrinologist up to a BMI of 32.5.

Max Healthcare organises a CME on: 'A practical approach to the management of Breast Cancer - An update for post-graduate and surgeons' on Sunday, 20th November 2011 at the auditorium Max Super Speciality Hospital(West Block), Saket.

Watch how Dr. Sherwin, an Obstetrician/Gynecologist is able to improve his practice workflows through CureMD's award winning Electronic Health Record (http://bit.ly/1Jec5Hu) and Practice Management system. The fact that he is able to create custom note templates goes really well with his requirements of having a flexible and state-of-the-art system. Read more http://www.curemd.com/testimonials.asp

There are various factors to be considered when outsourcing legal transcription services. This will help law firms save time and money. Global Transcripts has been the leading provider of legal transcription services for 15 years. Outsource your legal transcription processes to us for better revenue management. For more details about legal transcription,

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

Market Overview: Skin substitutes are natural, synthetic or biosynthetic materials, used to cover large wounds to restore at least some of the functions of the skin. Skin substitutes provides temporary or permanent wound closure and protect the wound from infection, further damage and water loss, and reduce pain. They also facilitate the growth of the normal skin over the wound. Skin substitutes provide a permanent solution and are used in the treatment of conditions like burns, trauma wounds, diabetes or venous ulcers, where skin grafts may not be possible. Market Dynamics: Rising chronic skin diseases is expected to drive the skin substitutes market. For instance, according to the global burden of disease study 2013, Skin conditions contributed around 1.79% to the global disease burden. According to the World Health Organization, about 132,000 melanoma skin cancers occur each year worldwide. Thus, the rising chronic diseases is increasing the demand for skin substitutes in the forecast period. Rising prevalence of diabetes is expected to boost the market. This is owing to the risk of developing a diabetic foot ulcer over the period of time in diabetic patients. For instance, WHO has reported that the incidence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is anticipated to rise from 171 million in 2000 to 366 million in 2030. Thus, as a consequence, the prevalence of diabetes related complications are expected to increase over the forecast period. There are several limitations to the commercially available skin substitutes, like reduced vascularization, poor mechanical integrity, failure to integrate, scarring, and immune rejection. Market Segmentation: Rise in preference for acellular skin substitutes to implant-based skin surgery is expected to drive the growth of the skin substitutes market. For instance, the American Society of Plastic Surgeons in 2012, reported that

Ciron cleantech provides complete validation of clean room equipments. For any cleanroom requirements, please contact us.

If you're one of those who find it difficult to deal with anger then this is for you. Learn how to handle anger better with the help of five tips from Max Healthcare.